r.chukwu
TL2 · Ibadan
Contributes reviews on supplier material. Based in Ibadan.
Joined 26 September 2025 · last posted 6d · groups: newcomer-guides
100 posts, newest first. Showing up to 150.
-
Journal club: LEADER as the historical anchor Replied, post #108 · Evidence › Journal club · 22 Jul 2026 · 21 likes On post #106 — agreed on the reasoning, with one qualification. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #100 · Analytics › Home & field testing · 19 Jul 2026 · 3 likes Adding the measurement that post #99 says would settle it. A control sample of known material run alongside is what turns a home test from an impression into a…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #35 · Practice › Interactions · 17 Jul 2026 · 1 like Narrowing post #34, because the general version has more than one answer. Where a published interaction study exists it usually reports an area-under-curve ratio, and…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #57 · Clinical › Bloodwork · 16 Jul 2026 · 2 likes The number people quote for Liver enzymes drifting is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Common supplements people ask about, assessed one at a time Replied, post #47 · Practice › Interactions · 14 Jul 2026 · 0 likes Everything in post #45 holds. The case it does not cover is the one I have. Anticoagulant questions come up regularly and are the clearest case for professional advice…
-
Asking a follow-up: new topic or new reply? Replied, post #49 · Start Here › How to Ask · 12 Jul 2026 · 0 likes Careful with the language on asking a follow-up. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #25 · Clinical › Comorbidities · 11 Jul 2026 · 3 likes Post #24 is the version of this I will quote in future. One addition. I would rather this thread reach "we do not know" about Osteoarthritis and mechanical versus…
-
Micro-titration: a disputed topic, argued properly Replied, post #102 · Practice › Dosing & titration · 9 Jul 2026 · 25 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
How shortages have affected compounding permissions Replied, post #22 · Access › Shortages · 8 Jul 2026 · 1 like This follows post #21 rather than contradicting it. Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #26 · Compounds › Retatrutide · 7 Jul 2026 · 14 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
Follow-up: UK access routes, dated and sourced Replied, post #9 · Regional › UK & Ireland · 4 Jul 2026 · 0 likes That is a fair summary of where the discussion has got to.
-
Revisiting: The best-written scientific paper you have read Replied, post #63 · Lounge › Off topic · 1 Jul 2026 · 1 like Two people in this thread mean different things by best-written scientific paper and are disagreeing about the definition while believing they are disagreeing about the…
-
Journal club: what we got wrong in an earlier session Replied, post #42 · Evidence › Journal club · 30 Jun 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. The short answer was in the first line; everything…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #47 · Clinical › Comorbidities · 28 Jun 2026 · 0 likes Offering a way to settle PCOS and metabolic overlap rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #59 · Analytics › Home & field testing · 27 Jun 2026 · 4 likes This is the sort of exchange that makes the archive worth searching.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #47 · Analytics › HPLC & UHPLC · 22 Jun 2026 · 8 likes Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280 it sees aromatic residues, so a peptide without tryptophan or…
-
Revisiting: Body image changing more slowly than the body Replied, post #7 · Wellbeing › Mental health · 18 Jun 2026 · 1 like That is the distinction I keep failing to hold on to. Written down now.
-
Racemisation and why it is invisible to a mass measurement Replied, post #100 · Analytics › Impurities & related substances · 14 Jun 2026 · 10 likes The arithmetic in post #97 is right; the assumption feeding it is the part to check. Aggregates may be a multiple of the monomer mass and may not elute at all under a…
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #10 · Clinical › Bloodwork · 12 Jun 2026 · 0 likes Answering the question post #6 raises rather than the one it answers. The most useful thing this subcategory does is help people tell an interesting result from an…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #11 · Start Here › Welcome · 7 Jun 2026 · 25 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #10 · Analytics › HPLC & UHPLC · 6 Jun 2026 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Why this subcategory is stricter about sourcing than most Replied, post #38 · Compounds › Secretagogues & GH axis · 3 Jun 2026 · 5 likes Narrowing post #37, because the general version has more than one answer. A mass result for a short peptide is more discriminating than for a long one, because a single…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #72 · Practice › Storage & stability · 2 Jun 2026 · 13 likes Helpful, and short, which on this subject is harder than long.
-
Citation sweep results: how many references did not say what was claimed Replied, post #102 · Meta › Wiki maintenance · 26 May 2026 · 1 like I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #15 · Start Here › Welcome · 19 May 2026 · 24 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #17 · Compounds › Oral incretins · 15 May 2026 · 0 likes Post #13 put the caveat in the right place and I want to underline it. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #45 · Practice › Reconstitution · 14 May 2026 · 0 likes Worth separating two things that post #43 runs together. Before the thread moves on from 5 mg vial — what is the sample size behind the claim? I am not being difficult;…
-
Does a peptide degrade silently, with no visual change? Replied, post #14 · Practice › Storage & stability · 22 Apr 2026 · 0 likes Peptide is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #41 · Sourcing › Logistics · 13 Apr 2026 · 7 likes Since Regional warehouse stock versus direct keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone…
-
Follow-up: Search filters: what is missing Replied, post #70 · Meta › Site feedback · 6 Apr 2026 · 0 likes That would also be the fastest way for a new member to understand what R6 actually catches, which is narrower than people assume from the text. It reads as pedantry…
-
Choosing which test to pay for, given a fixed budget Replied, post #53 · Sourcing › Independent verification · 4 Apr 2026 · 8 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. A modest claim, modestly supported.
-
Grapefruit: why this class is not the class that cares Replied, post #65 · Practice › Interactions · 21 Mar 2026 · 8 likes On post #61 — agreed on the reasoning, with one qualification. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Search filters: what is missing Replied, post #36 · Meta › Site feedback · 15 Mar 2026 · 7 likes I would keep search filters and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
-
Revisiting: Maintainer handover: how it works Replied, post #37 · Meta › Wiki maintenance · 7 Mar 2026 · 2 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection. I am not the right…
-
Forced degradation studies: designing one that is informative Replied, post #14 · Analytics › Method validation · 3 Mar 2026 · 3 likes Forced degradation under acid, base, oxidation, heat and light is how specificity is actually demonstrated. The chromatograms from that work are more informative than…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #35 · Research Methods › N-of-1 designs · 23 Feb 2026 · 29 likes On Pre-registering a personal experiment, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of…
-
Moderation log format change Replied, post #29 · Meta › Announcements · 15 Feb 2026 · 27 likes Post #26 answers the question as asked. The question underneath it is different. Adding a small correction to the moderation log format change summary above rather than…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #23 · Outcomes › Body composition · 5 Feb 2026 · 0 likes Post #22 is the version of this I will quote in future. One addition. Neither method is capable of detecting the month-to-month changes that people report detecting…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #52 · Documentation › Wiki requests · 24 Jan 2026 · 2 likes Post #48 describes the usual case. This is about the unusual one. A page that would need to be rewritten every quarter is usually better as a topic with a good marked…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #28 · Data & Tools › Calculators · 22 Jan 2026 · 20 likes No disagreement from me. Posting only so the question does not look ignored.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #92 · Compounds › Semaglutide · 13 Jan 2026 · 11 likes Post #90 put the caveat in the right place and I want to underline it. The mass figure differs between sources because of how the different entities report it. The…
-
Reading an interaction checker output critically Replied, post #89 · Practice › Interactions · 11 Jan 2026 · 2 likes Noted, and thank you for writing it out rather than summarising it.
-
A partial dose because the pen emptied mid-injection Replied, post #102 · Practice › Administration · 10 Jan 2026 · 22 likes On post #98 — agreed on the reasoning, with one qualification. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #28 · Practice › Interactions · 4 Jan 2026 · 0 likes Post #26 describes the usual case. This is about the unusual one. Anticoagulant questions come up regularly and are the clearest case for professional advice rather…
-
When to stop reading forums, including this one Replied, post #69 · Wellbeing › Mental health · 31 Dec 2025 · 0 likes I had written a reply contradicting post #65 and deleted it. Here is what survived. Relationship with food changing is one of the most commonly described experiences…
-
Tracking a preprint to publication: a worked example Replied, post #139 · Evidence › Preprints · 14 Dec 2025 · 18 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Prescription requirements and telehealth models Replied, post #62 · Sourcing › Regulatory · 12 Dec 2025 · 29 likes The failure mode on prescription requirements and telehealth models is boring rather than dramatic. It is almost always the step everyone assumes was done correctly…
-
Amylin receptor signalling and satiety — what changed since Replied, post #3 · Pharmacology › Receptor biology · 9 Dec 2025 · 2 likes Picking up post #2: that is the part I would want checked first. Distinguishing three things in the Amylin receptor signalling and satiety discussion that keep getting…
-
Publication bias detection and its low power — does this still hold? Started this topic · Evidence › Meta-analyses · 28 Nov 2025 · 10 likes The question in the title: Publication bias detection and its low power — does this still hold? I will give what I have already checked below so nobody repeats it.…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #64 · Compounds › Oral incretins · 21 Nov 2025 · 7 likes Post #63 is right about the mechanism and I think understates the practical bit. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #72 · Analytics › COA interpretation · 17 Nov 2025 · 31 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #118 · Practice › Storage & stability · 3 Nov 2025 · 21 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. The claim is narrower than it sounds,…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #3 · Practice › Side effects · 12 Oct 2025 · 9 likes Reading this Constipation management thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 5 likes Reading back through, this was answered upthread and I missed it. My fault.
-
The headache that turns out to be dehydration Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 29 Sep 2025 · 0 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm. Not a strong opinion, just a consistent one.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #126 · Evidence › Study critique · 16 Sep 2025 · 32 likes Two people in this thread mean different things by Reverse causation and are disagreeing about the definition while believing they are disagreeing about the facts.…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #75 · Devices › Cold chain · 11 Sep 2025 · 0 likes Taking post #73 at face value and following it one step further. A definition problem is doing most of the work in this Airline travel discussion. Once the term is…
-
Documentation that appears only after payment Replied, post #19 · Sourcing › Red flags · 6 Sep 2025 · 4 likes Having read the whole documentation thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #55 · Practice › Dosing & titration · 5 Sep 2025 · 27 likes Post #51 describes the usual case. This is about the unusual one. Where the Escalating every six weeks instead discussion usually stalls is that nobody wants to say "I…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #26 · Compounds › Tirzepatide · 28 Aug 2025 · 29 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #83 · Evidence › Journal club · 21 Aug 2025 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Asking about a compound your prescriber has not heard of Replied, post #131 · Clinical › Prescriber conversations · 19 Aug 2025 · 22 likes I read post #127 twice before replying, because I had assumed the opposite. Prescription logistics: confirm whether it will be filled locally, requires mail order, or…
-
Hypertension improvement and when medication needs revisiting Replied, post #7 · Clinical › Comorbidities · 13 Aug 2025 · 0 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. On hypertension improvement, I would rather understate and be corrected upward than…
-
Are there stupid questions here? A staff answer, at length Replied, post #32 · Start Here › Welcome · 2 Aug 2025 · 0 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
How to research a compound with no human data without deceiving yourself Replied, post #38 · Compounds › Other compounds · 1 Aug 2025 · 1 like A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
-
A preprint whose numbers changed substantially at publication Replied, post #5 · Evidence › Preprints · 29 Jul 2025 · 0 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. A preprint reporting a null result is more likely to stay a preprint, which biases…
-
Journal club: STEP 8 and the fairness of the comparator dose Replied, post #3 · Evidence › Journal club · 23 Jul 2025 · 17 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I am…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #81 · Compounds › Semaglutide · 22 Jul 2025 · 0 likes On post #79 — agreed on the reasoning, with one qualification. Injection site does not appear to matter much for semaglutide exposure. The published comparisons of…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #15 · Compounds › Secretagogues & GH axis · 21 Jul 2025 · 17 likes Answering the question post #11 raises rather than the one it answers. A mass result for a short peptide is more discriminating than for a long one, because a single…
-
Why the timeline is on the right and not the left Replied, post #42 · Meta › Site feedback · 17 Jul 2025 · 7 likes Timeline sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #51 · Sourcing › Regulatory · 15 Jul 2025 · 20 likes I read post #48 twice before replying, because I had assumed the opposite. Approval versus licensing: a compound can be approved for a specific indication in one…
-
Ipamorelin selectivity claims and where they came from Replied, post #56 · Compounds › Secretagogues & GH axis · 12 Jul 2025 · 28 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. My position on ipamorelin selectivity claims is current rather than settled. I have…
-
Consistent declarations and why they matter more than clever ones — a second dataset Replied, post #3 · marked as the solution · Sourcing › Logistics · 12 Jul 2025 · 31 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Interpreting a composition change that is within the error bars Replied, post #11 · Outcomes › Body composition · 3 Jul 2025 · 18 likes A single scan is a snapshot with error bars nobody prints. Two scans give you a difference with larger error bars. I would want a second opinion before relying on that.
-
Why plausible mechanism is not evidence of effect Replied, post #18 · Compounds › Repair & healing peptides · 28 Jun 2025 · 26 likes Agreed on all of that, and I have nothing to add to it.
-
Half-life, steady state, and accumulation worked through Replied, post #82 · Pharmacology › Pharmacokinetics · 8 Jun 2025 · 31 likes Taking post #79 at face value and following it one step further. The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the…
-
Half-life, steady state, and accumulation worked through Replied, post #61 · Pharmacology › Pharmacokinetics · 3 Jun 2025 · 4 likes Worth separating two things that post #57 runs together. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume…
-
A well-designed study with a badly written abstract Replied, post #82 · Evidence › Study critique · 14 May 2025 · 10 likes I have no financial interest in anything named in this thread and I want to say so before I comment on well-designed study, because it is the sort of subject where it…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #11 · Compounds › Repair & healing peptides · 10 May 2025 · 3 likes Source for the TB-500 and thymosin beta-4 figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
-
A supplier that answers analytical questions with restated claims Replied, post #57 · Sourcing › Red flags · 14 Apr 2025 · 18 likes The documentation on supplier is better than this thread and I say that as someone who has posted in the thread.
-
Validating a method you did not develop — does this still hold? Replied, post #63 · Analytics › Method validation · 2 Mar 2025 · 31 likes Worth separating two things that post #61 runs together. Adding the boring version of Validating a method, because the interesting version keeps getting posted and the…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #14 · Compounds › Semaglutide · 17 Feb 2025 · 0 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Protein density versus volume when you cannot eat much Replied, post #6 · Nutrition & Training › Protein & intake · 22 Jan 2025 · 13 likes On post #4 — agreed on the reasoning, with one qualification. The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #58 · Sourcing › Regulatory · 6 Jan 2025 · 0 likes A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #123 · Compounds › Oral incretins · 28 Dec 2024 · 1 like Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
-
A promotion I argued against, and why I lost Replied, post #30 · Documentation › Doc review · 15 Dec 2024 · 4 likes No disagreement from me. Posting only so the question does not look ignored.
-
What changed in 2026, by region Replied, post #8 · marked as the solution · Access › International · 4 Dec 2024 · 20 likes Post #6 and I disagree about the size of the effect, not about the direction. A regional experience posted here should say which year it describes. The archive keeps…
-
[2026 update] New subcategory: rationale and scope Replied, post #33 · Meta › Announcements · 30 Nov 2024 · 5 likes I disagree with the framing of New subcategory above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #29 · Nutrition & Training › Protein & intake · 30 Nov 2024 · 1 like Adding the measurement that post #28 says would settle it. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean…
-
Why "any advice?" is the least effective ending for a post Replied, post #82 · Start Here › How to Ask · 28 Nov 2024 · 28 likes Post #81 answers the question as asked. The question underneath it is different. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #51 · Clinical › Prescriber conversations · 11 Nov 2024 · 32 likes Post #49 and I disagree about the size of the effect, not about the direction. Bringing a record of symptoms with dates and severities makes an assessment materially…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #25 · Practice › Interactions · 10 Nov 2024 · 0 likes Posting my Grapefruit numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #59 · Devices › Syringes & needles · 2 Nov 2024 · 21 likes The thing about Dead volume across syringe that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #95 · Analytics › COA interpretation · 25 Oct 2024 · 26 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #56 · Analytics › Method validation · 21 Oct 2024 · 12 likes Coming back to post #52, because the follow-up matters more than the original answer. Robustness: the method gives consistent results when minor parameters vary. Tested…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #6 · Compounds › Oral incretins · 18 Oct 2024 · 3 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #64 · Clinical › Bloodwork · 28 Sep 2024 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #41 · Compounds › Retatrutide · 16 Sep 2024 · 10 likes Narrowing post #40, because the general version has more than one answer. Offering a way to settle hepatic effects of glucagon receptor rather than another opinion…
-
Blind submission and why it changes minds Replied, post #57 · Sourcing › Independent verification · 9 Sep 2024 · 4 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
How to ask for a dose change without antagonising anyone Replied, post #11 · Clinical › Prescriber conversations · 3 Aug 2024 · 0 likes Narrowing post #8, because the general version has more than one answer. A question phrased as "what would you want to see before considering X" is answerable and is…